Buscar
Mostrando ítems 1-6 de 6
Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days
(2013)
BACKGROUND: From 2001 to March 2006, Planned Parenthood Federation of America (Planned Parenthood) health centers throughout the United States provided medical abortions principally by a regimen of oral mifepristone, ...
Medical management of abortion, 2018
(World Health Organization, 2018)
La atención médica relacionada con el aborto abarca el tratamiento de diversas afecciones clínicas, incluido el aborto espontáneo e inducido (embarazos tanto viables como no viables), el aborto incompleto y la muerte fetal ...
Achievements of the FIGO Initiative for the Prevention of Unsafe Abortion and its Consequences in South-Southeast Asia.
(International Federation of Gynecology and Obstetrics, 2014)
Since 2008, the FIGO Initiative for the Prevention of Unsafe Abortion and its Consequences has contributed to ensuring the substitution of sharp curettage by manual vacuum aspiration (MVA) and medical abortion in selected ...
Landscape Assessment: Leveraging the role of national distributors to increase access to MA combi-packs in Africa. January 2019/Report to RHSC.
(Mann Global Health, 2019)
Se estima que cada año ocurren 56 millones de abortos, y más de la mitad de ellos son inseguros.
El aborto médico (MA) usando una combinación de mifepristona y misoprostol es un método seguro y alternativa efectiva al ...
A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries
(Contraception, 2020-01)
IPPF y Gynuity Health Projects realizaron un análisis de lo que viene inserto en los empaques de misoprostol, mifepristona y combi-packs en diversos países con el fin de ver su precisión y si contenían información integral. ...